Clinical trial
Taiwan β-Thalassemia Major Real-World Study for Luspatercept
NCT06596642 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Taiwan β-Thalassemia Major Real-World Study for Luspatercept
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 21, 2024
- Completion date
- December 17, 2026
- Enrollment
- 61 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
β-thalassemia major